Notice of AGM

RNS Number : 7712O

Ergomed plc

21 May 2018

 

PRESS RELEASE

Annual Report and Notice of AGM

London, UK - 21 May 2018: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the pharmaceutical industry, announces that it will host its Annual General Meeting at the offices of Covington & Burling LLP, 265 Strand, London WC2R 1BH at 9.30am on Tuesday 12^th June 2018.

The Annual Report and Accounts for the year ended 31 December 2017, Notice of AGM and Proxy have been mailed to shareholders today, Monday 21^st May 2018. The Annual Report and Accounts will be available on the Company's website: www.ergomedplc.com. 

- ENDS -

Enquiries:

Ergomed plc	Tel: [phone]
Stephen Stamp (Chief Executive Officer)
Numis Securities Limited	Tel: [phone]
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black (Joint Broker)
N+1 Singer (Joint Broker)	Tel: [phone]
Alex Price
Consilium Strategic Communications - for UK enquiries	Tel: [phone]
Chris Gardner / Mary-Jane Elliott Ivar Milligan / Philippa Gardner	[e-mail]
MC Services - for Continental European enquiries	Tel: [phone]
Anne Hennecke

About Ergomed

Ergomed provides specialist services to the pharmaceutical industry and develops drugs both wholly-owned and through partnerships. Ergomed's fast-growing, profitable service offering spans all phases of clinical development and post-approval pharmacovigilance and medical information. Drawing on more than 20 years of expertise in drug development, Ergomed has established a portfolio of drug development partnerships and programmes, including wholly-owned proprietary products for the treatment of surgical bleeding. For further information, visit: http://ergomedplc.com.

 

END

 

 

NOALLFVSEFILFIT